Evidence map›Paper›PMID 40384743›Full record

ReviewMethodist DeBakey cardiovascular journal2025

History of Heart Transplant: Setting the Stage.

Farhan Ishaq, Ashrith Guha

Abstract readHistorical ArticleReview
In one paragraph

Review in Methodist DeBakey cardiovascular journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Heart Transplant: A Never-Ending Story.Journal of clinical medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Farhan IshaqHouston Methodist DeBakey Heart & Vascular Center, Houston Methodist, Houston, Texas, US.ORCID https://orcid.org/0000-0002-2978-860X
Ashrith GuhaHouston Methodist DeBakey Heart & Vascular Center, Houston Methodist, Houston, Texas, US.ORCID https://orcid.org/0000-0002-7246-9508

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart transplantation is a marvel of modern medicine for patients with end-stage heart failure. Decades of research and surgical innovation have overcome challenges in immunology, organ preservation, and patient care. From the earliest heart transplants on canines and primates, the field evolved through immunosuppressive therapies, development of the bioptome for endomyocardial biopsy and, recently, the use of cell free DNA and molecular microscopy for assessing rejection. Newer developments in organ preservation systems and transport systems bring remarkable increases in the availability of donors.

Indexed as

Heart FailureHeart TransplantationAnimalsGraft RejectionGraft SurvivalHistory, 19th CenturyHistory, 20th CenturyHistory, 21st CenturyHumansImmunosuppressive AgentsOrgan PreservationTreatment OutcomeImmunosuppressive Agentscardiac transplantheart transplanthistory of heart transplanttransplantation

Identifiers

PMID40384743
PMCPMC12082442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.